Raptiva in Palm and Sole Psoriasis

PHASE4

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union

Conditions

Chronic Plaque Psoriasis

Interventions

BIOLOGICAL: Efalizumab (Raptiva)
BIOLOGICAL: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany